Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01371981 · OUTCOME

Remission Rate After 1 Course of Therapy

Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · Source last updated 2026-06-02

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
4 weeks

What was measured

The proportion of patients achieving remission after 1 course of therapy will be estimated along with a corresponding 95% confidence interval.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
description
The proportion of patients achieving remission after 1 course of therapy will be estimated along with a corresponding 95% confidence interval.
reporting Status
NOT_POSTED
time Frame
4 weeks
title
Remission Rate After 1 Course of Therapy
type
OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice